Article
Designed improvement to T-cell immunotherapy by multidimensional single cell profiling.
Journal for immunotherapy of cancer - 1 Mar 2021
Bandey Irfan N, Adolacion Jay R T, Romain Gabrielle, Paniagua Melisa Martinez, An Xingyue, Saeedi Arash, Liadi Ivan, You Zheng, Rajanayake Rasindu B, Hwu Patrick, Singh Harjeet, Cooper Laurence Jn, Varadarajan Navin
Abstract excerpt
BACKGROUND: Adoptive cell therapy based on the infusion of chimeric antigen receptor (CAR) T cells has shown remarkable efficacy for the treatment of hematologic malignancies. The primary mechanism of action of these infused T cells is the direct killing of tumor cells expressing the cognate antigen. However, understanding why only some T cells are capable of killing, and identifying mechanisms that can improve...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
